Digital Patient Education Platform in Head and Neck Cancer

Sponsor
University of British Columbia (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT05211778
Collaborator
(none)
35
1
2
40.7
0.9

Study Details

Study Description

Brief Summary

Head and neck cancer is a disease that has a particular propensity for treatment-related morbidity. It is hypothesized that patients who are more involved in their care in hospital and who are actively provided with more treatment-related education may report increased satisfaction and have improved overall outcomes. The investigators aim to determine whether delivery of patient-centred education in a multimedia format via a digital platform has an impact on overall satisfaction and perceived quality of medical care.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Digital Education Group
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
35 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Care Provider, Investigator)
Primary Purpose:
Supportive Care
Official Title:
Post-Operative Patient-Centred Care Education Administration in Head and Neck Cancer Patients - A Digital Platform
Actual Study Start Date :
Jan 8, 2019
Actual Primary Completion Date :
Mar 26, 2020
Anticipated Study Completion Date :
Jun 1, 2022

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Control Group

This group will continue to receive the routine standard of care during their treatment journey.

Experimental: Digital Education Group

In addition to the standard of care, this group will complete an audiovisual digital education module during their postoperative stay in hospital.

Behavioral: Digital Education Group
Multimedia education provided to the intervention group via a digital tablet

Outcome Measures

Primary Outcome Measures

  1. Patient Satisfaction [From date of surgery until the date of discharge. The number of days patients will remain in hospital after surgery can range from 7-14 days.]

    Measured via a 5-point Likert scale from a survey collected on discharge day

Secondary Outcome Measures

  1. Perceived quality of medical care [From date of surgery until the date of discharge. The number of days patients will remain in hospital after surgery can range from 7-14 days.]

    Measured via a 5-point Likert scale from a survey collected on discharge day

Eligibility Criteria

Criteria

Ages Eligible for Study:
19 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients aged 19 years old or above

  • Patients seen in outpatient clinic who are scheduled to undergo reconstructive head and neck surgeries for a confirmed oral or oropharyngeal cancer diagnosis.

Exclusion Criteria:
  • Patients who are unable to use a digital tablet

  • Patients who do not speak or read English

  • Individuals unable to understand the purpose, methods and conduct of this study

  • Patients unwilling to provide informed consent

Contacts and Locations

Locations

Site City State Country Postal Code
1 Vancouver General Hospital Vancouver British Columbia Canada

Sponsors and Collaborators

  • University of British Columbia

Investigators

  • Principal Investigator: Eitan Prisman, MD, FRCSC, University of British Columbia

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Eitan Prisman, Associate Professor, University of British Columbia
ClinicalTrials.gov Identifier:
NCT05211778
Other Study ID Numbers:
  • H16-01039
First Posted:
Jan 27, 2022
Last Update Posted:
Jan 27, 2022
Last Verified:
Jan 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Eitan Prisman, Associate Professor, University of British Columbia
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 27, 2022